|
|||||||||||||||
 | |||||||||||||||
|
 |
|
|
Detailed Insider History For:
|
|
# |
View Form |
|
Insider Title |
Company Name |
Ticker |
Trans Type |
Dollar Value |
Shares Traded |
Trans Date From |
Trans Date To |
Trans Price From |
Trans Price To |
Total Holdings |
Delta % Owned |
Owned |
Other Info |
SIC Code |
SIC Sector |
SIC Industry |
SIC Sub-Industry |
Input Date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
 |
DIR |
JB |
--- |
24,311 |
--- |
6/18/24 |
--- |
--- |
163,839 |
17.4 |
D |
R |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
6/21/24 - 4:05:08 pm | |||||||||||||
2 |
|
DIR |
AS |
$143,198 |
22,766 |
--- |
6/10/24 |
--- |
$6.29 |
139,528 |
-14.0 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
6/12/24 - 4:05:03 pm | |||||||||||||
3 |
|
DIR |
AS |
$196,250 |
2,500 |
--- |
5/28/24 |
--- |
$78.50 |
28,617 |
-8.0 |
D |
10b |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
5/30/24 - 4:32:52 pm | |||||||||||||
4 |
|
DIR |
JB |
--- |
2,635 |
--- |
5/9/24 |
--- |
--- |
31,117 |
9.3 |
D |
--- |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
5/13/24 - 5:03:58 pm | |||||||||||||
5 |
|
DIR |
JB |
--- |
22,350 |
--- |
6/20/23 |
--- |
--- |
162,294 |
16.0 |
D |
R |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
6/22/23 - 5:29:51 pm | |||||||||||||
6 |
|
DIR |
JB |
--- |
2,012 |
--- |
5/11/23 |
--- |
--- |
28,482 |
7.6 |
D |
--- |
2835 |
Manufacturing |
Chemicals And Allied Products |
In Vitro & In Vivo Diagnostic Substances
|
5/15/23 - 6:45:46 pm | |||||||||||||
7 |
|
DIR |
JS |
$245,449 |
16,095 |
--- |
11/21/22 |
--- |
$15.25 |
--- |
All |
D |
R |
2836 |
Manufacturing |
Chemicals And Allied Products |
Biological Products, (No Disgnostic Substances)
|
11/21/22 - 4:59:15 pm | |||||||||||||
|
|
||||||||||||||||||||||||||||
| |
